Sioux Falls, SD, April 21, 2010--AlphaGenix announced that it will be moving its corporate offices and regenerative medicine laboratory to the Purdue Research Park at Purdue University in West Lafayette, Indiana at the end of May.   The Purdue Research Park (PRP) is an excellent location for the expansion of AlphaGenix, which will greatly benefit the company's product development.  PRP is one of the largest of its kind in the U.S. and has 725 acres, 52 buildings, more than 160 companies and 3,100 employees in the park.  This will allow AlphaGenix to have access to Purdue's instrumentation and facilities and the ability to initiate collaborations with Purdue researchers.
 

Sioux Falls, SD, May 1, 2009 -- AlphaGenix, Inc. moved into a newly-constructed 21,000 square foot lab facility.  The facility includes state-of-the-art wet lab space, a Class 100 cleanroom for manufacturing and scientific research, a biosafety facility for the containment of biosafety level 1-3 adventitious agents and a light sensitive room for the development of light sensitive biopolymers.   The company also utilizes a shared facility for advanced scientific imaging and visualization.  The facility has private and open office space, an advanced internet and telecommunications network, security, conferencing and a library.
 

Sioux Falls, SD, December 15, 2008 -- Stephen Hall, Ph.D., President of AlphaGenix, Inc., gave a presentation at The American Society for Cell Biology annual meeting in San Francisco, CA.  His appearance was sponsored by Sigma-Aldrich and was entitled "The effects of novel synthetic and natural biomaterials on in vitro cell systems". The presentation discussed the design and application of 3-dimensional biomaterials comprised of extracellular matrix components and peptide nanofibers that have cell culture and tissue engineering applications.

 

St. Louis, MO, Nov. 13, 2008 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced a distribution agreement with AlphaGenix, Inc., a leading developer and manufacturer of products for basic and clinical life science research. Sigma-Aldrich will now be the exclusive supplier of AlphaGenix-developed antibodies and research tools for the fields of regenerative medicine and stem cell biology. This partnership will further augment Sigma-Aldrich's growing product portfolio of life science tools for stem cell research (read full press release).